Clinical trial
An Open Extension Study to Phase IIb Study of Clozapine in Patients With Treatment-resistant Schizophrenia
NCT00154258 is registered in ClinicalTrials.gov with Novartis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Extension Study to Phase IIb Study of Clozapine in Patients With Treatment-resistant Schizophrenia
- Lead sponsor
- Novartis
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2001
- Completion date
- December 31, 2009
- Enrollment
- 19 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.